App-Quantinova.ai

169 Abstracts

The Difference Between Cystatin C- and Creatinine-Based Kidney Function Assessment is Associated With Clinical Outcomes, Quality of Life and Frailty in Patients With Heart Failure and Reduced Ejection Fraction Insights From PARADIGM-HF

Alberto Pinsino - American Heart Association (AHA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart failure with reduced ejection fraction

Angiotensin II

“Mississippi Mud” Hypercreatinemia Syndrome

Aparna Baburaj - National Kidney Foundation (NKF) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

Piperacillin/tazobactam

Cystatin C and risk of incident CHD and stroke among African Americans-Jackson Heart Study

Pradyumna Agasthi - Transcatheter Cardiovascular Therapeutics (TCT) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Myocardial infarction

Cysteine Hydrochloride

Cystatin C Predicts Major Cardiovascular Events in Patients with Coronary Artery Disease Both among Patients with Type 2 Diabetes and in Nondiabetic Individuals

ARTHUR MADER - American Diabetes Association (ADA) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Coronary Artery Disease

N/A

Serum Cystatin C as early marker for AKI of Patients after Coronary Angiography: a Prospective, Observational Study in Mexican population

L. Rizo Topete - International Society of Nephrology (ISN) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

N/A

MINERAL BONE DISORDERS IN CHILDREN WITH SICKLE CELL ANEMIA AND ACUTE KIDNEY INJURY

A. BATTE - International Society of Nephrology (ISN) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Vitamin D deficiency

Ergocalciferol

The Clinical Significance of the Glomerular Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Renal Function of Caucasian Patients with Compound Heterozygosity for Hb S and β-Thalassemia

Ioannis Papassotiriou - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Thalassemia

Interleukin

Abnormal Free Light Chains in Individuals with African Ancestry Screened for Monoclonal Gammopathy: Definition of New Reference Range Accounting for Renal Function and Race

Luca Bertamini - American Society of Hematology (ASH) , 2022

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Monoclonal gammopathy

Lanthanum carbonate

Serum Cystatin C is an Early Predictor of Acute Renal Injury in Infants after Cardiac Surgery with Cardiopulmonary Bypass

Maher Abadeer - Pediatric Academic Societies (PAS) , 2022

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Acute renal failure

N/A

Filters

169 Abstracts